Click through the PLOS taxonomy to find articles in your field.
For more information about PLOS Subject Areas, click
here.
Loading metrics
Open Access
Correction
Correction: Serum matrix metalloproteinase 3 levels are associated with an effect of iguratimod as add-on therapy to biological DMARDs in patients with rheumatoid arthritis
Nao Tokai,
Shuzo Yoshida,
Takuya Kotani,
Ayaka Yoshikawa,
Yuko Kimura,
Youhei Fujiki,
Yoko Matsumura,
Tohru Takeuchi,
Shigeki Makino,
Shigeki Arawaka
Correction: Serum matrix metalloproteinase 3 levels are associated with an effect of iguratimod as add-on therapy to biological DMARDs in patients with rheumatoid arthritis